Company news from the 07/18/06 News Brief

Share this article:
Santarus, a specialty pharmaceutical company focused on products treating gastrointestinal diseases, has launched a new full-service Web site to coincide with the launch of its new capsule formulation Zegerid, an immediate release oral proton pump inhibitor for nighttime acid control. The site, zegerid.com, was designed and developed by Compass Healthcare Communications.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Apple selfies spur diabetes donations

Jazz apples has launched a Crunch to Contribute campaign to raise money for one of two diabetes associations.

Baxter seeks Cambridge, Mass. HQ

Illinois may be tempted to offer tax incentives for the firm to stay put.

FDA wants Alexion to clean up

FDA inspectors have cited the manufacturer of the rare-disease drug Soliris (eculizumab) for poor manufacturing practices.